IN8bio’s treatment of malignant glioma was granted orphan designation from the FDA, according to a post to the agency’s website. Reference Link
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on INAB:
IN8bio’s treatment of malignant glioma was granted orphan designation from the FDA, according to a post to the agency’s website. Reference Link
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on INAB: